SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis

PURPOSE: Heparanase promotes myeloma growth, dissemination and angiogenesis through modulation of the tumor microenvironment, thus highlighting the potential of therapeutically targeting this enzyme. SST0001, a non-anticoagulant heparin with anti-heparanase activity was examined for its inhibition o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ritchie, Joseph P., Ramani, Vishnu C., Ren, Yongsheng, Naggi, Annamaria, Torri, Giangiacomo, Casu, Benito, Penco, Sergio, Pisano, Claudio, Carminati, Paolo, Tortoreto, Monica, Zunino, Franco, Vlodavsky, Israel, Sanderson, Ralph D., Yang, Yang
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3060291/
https://ncbi.nlm.nih.gov/pubmed/21257720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2476
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados